DNM2mutations were preferentially occurred in AML with CEBPA mutation (11/18, 61.1%), or RUNX1::RUNX1T1 fusion gene (6/18, 33.3%). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.